ARCHIVES

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

This article is from The Cancer Letter archive.

Vol. 04 No. 47 | November 24, 1978

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

House Bill Gives NCI $48 Mil. Less Than Clinton Requested

July 8, 1994

Regulatory Agencies: FDA Proposes “Treatment IDE” Funding Opportunities:

February 7, 1997

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

Ford Asks NCAB for Scientific Basis For Regulation Of Tar and Nicotine Content Of Cigarettes By Dec.

October 25, 1974